Effect of glycoprotein IIIa PlA2 polymorphism on outcome of patients with stable coronary artery disease and effect of smoking

American Journal of Cardiology

Volumn 93, Issue 12, 2004, Pages 1469-1472

  Lopes, Neuza H M ^a   Pereira, Alexandre C ^b   Hueb, Whady ^b   Soares, Paulo R ^b   Lanz, Jose R ^b   Gersh, Bernard J ^b   De Oliveira, Sergio ^b   Cesar, Luiz A M ^b   Ramires, Jose F ^b   Krieger, Jose Eduardo ^b  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOPROTEIN IIIA;

ADULT; AGED; ALLELE; ANGINA PECTORIS; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DNA POLYMORPHISM; FEMALE; GENETIC VARIABILITY; GENOTYPE; HEART DEATH; HEART INFARCTION; HEART LEFT VENTRICLE FUNCTION; HEART MUSCLE REVASCULARIZATION; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK FACTOR; SMOKING;

EID: 2942520992     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2004.03.005     Document Type: Article

References (21)

1. Ardissino D., Mannucci P.M., Merlini P.A., Duca F., Fetiveau R., Tagliabue L., Tubaro M., Galvani M., Ottani F., Ferrario M., et al. Prothrombotic genetic risk factors in young survivors of myocardial infarction. Blood. 94:1999;46-51
2. Hueb W, Soares PR, Gersh B, Cesar LAM, Luz PL, Puig LB, Martinez EM, Oliveira SA, Ramires JAF. The Medicine, Angioplasty, or Surgery Study (MASS-II): a randomized, controlled clinical trial of three therapeutic strategies for multivessel coronary artery disease, one year results. J Am Coll Cardiol 2004;43:1743-1751.
3. Ridker P.M., Hennekens C.H., Schmitz C., Stampfer M.J., Lindpaintner K. PIA1/A2 polymorphism of platelet glycoprotein IIIa and risks of myocardial infarction, stroke, and venous thrombosis. Lancet. 349:1997;385-388
4. Newman P.J., Derbes R.S., Aster R.H. The human platelet alloantigens, PlA1 and PlA2, are associated with a leucine33/proline33 amino acid polymorphism in membrane glycoprotein IIIa, and are distinguishable by DNA typing. J Clin Invest. 83:1989;1778-1781
5. Hueb W.A., Soares P.R., Almeida de Oliveira S., Ariê S., Cardoso R.H.A., Wajsbrot D.B., Cesar L.A.M., Jatene A.D., Ramires J.A.F. Five-year follow-up of the Medicine, Angioplasty, or Surgery Study (MASS) a prospective, randomized trial of medical therapy, balloon angioplasty, or bypass surgery for single proximal left anterior descending coronary artery stenosis. Circulation. 100:(suppl II):1999;107-113
6. Lefkovits J., Plow E.F., Topol E.J. Platelet glycoprotein IIb/IIIa receptors in cardiovascular medicine. N Engl J Med. 332:1994;1553-1559
7. Handin R.I. Platelets and coronary artery disease. N Engl J Med. 334:1996;1126-1128
8. Shattil S.J. Function and regulation of the b3 integrins in hemostasis and vascular biology. Thromb Haemost. 74:1995;149-155
9. Gimbrone M.A.J., Cybulsky M.I., Kune N., Resnick N. Vascular endothelium. An integrator of pathophysiological stimuli in atherogenesis. Ann NY Acad Sci. 748:1995;122-132
10. Ruoslahti E., Engvall E. Integrins and vascular extracellular matrix assembly. J Clin Invest. 99:1997;1149-1152
11. Glass C.K., Witztum J.L. Atherosclerosis the road ahead. Cell. 104:2001;503-516
12. Feng D., Lindpaintner K., Larson M.G., Rao V.S., O'Donnell C.J., Lipinska I., Schmitz C., Sutherland P.A., Silbershatz H., D'Agostino R.B., et al. Increased platelet aggregability associated with platelet GPIIIa PlA2 polymorphism the Framingham Offspring Study. Arterioscler Thromb Vasc Biol. 19:1999;1142-1147
13. Zotz R.B., Deitenbeck R., Rehfeld I.S.B., Maruhn-Debowski B., Giers G., Bauer H., Winkelmann B.R., Scharf R.E. Increased platelet sensitivity related to GPIIIa polymorphism (HPA-b/PLA2). Circulation. 96:(suppl):1997;I-664-I-665
14. Weiss E.J., Bray P.F., Tayback M., Schulman S.P., Kickler T.S., Becker L.C., Weiss J.L., Gerstenblith G., Goldschmidt-Clermont P.J. A polymorphism of a platelet glycoprotein receptor as an inherited risk factor for coronary thrombosis. N Engl J Med. 334:1996;1090-1094
15. Aleksic N., Juneja H., Folsom A.R., Ahn C., Boerwinkle E., Chambless L.E., Wu K.K. Platelet Pl(A2) allele and incidence of coronary heart disease results from the Atherosclerosis Risk In Communities (ARIC) Study. Circulation. 102:2000;1901-1905
16. Goldschmidt-Clermont P.J., Cooke G.E., Eaton G.M., Binkley P.F. PlA2, a variant of GPIIIa implicated in coronary thromboembolic complications. J Am Coll Cardiol. 36:2000;90-93
17. Gardemann A., Humme J., Stricker J., Nguyen Q.D., Katz N., Philipp M., Tillmanns H., Hehrlein F.W., Rau M., Haberbosch W. Association of the platelet glycoprotein IIIa PIA1/A2 gene polymorphism to coronary artery disease but not to nonfatal myocardial infarction in low risk patients. Thromb Haemost. 80:1998;214-217
18. Zhu M.M., Weedon J., Clark L.T. Meta-analysis of the association of platelet glycoprotein IIIa PlA1/A2 polymorphism with myocardial infarction. Am J Cardiol. 86:2000;1000-1005
19. Castelnuovo A., de Gaetano G., Donati M.B., Iacoviello L. Platelet glycoprotein receptor IIIa polymorphism PlA1/PlA2 and coronary risk a meta-analysis. Thromb Haemost. 85:2001;626-633
20. Walter D.H., Schachinger V., Elsner M., Dimmeler S., Zeiher A.M. Platelet glycoprotein IIIa polymorphisms and the risk of coronary stent thrombosis. Lancet. 350:1997;1217-1219
21. Bray P.F., Cannon C., Goldschmidt-Clermont P., Moye L.A., Pfeffer M.A., Sacks F.M., Braunwald E. The platelet Pl(A2) and angiotensin-converting enzyme (ACE) D allele polymorphisms and the risk of recurrent events after acute myocardial infarction. Am J Cardiol. 88:2001;347-352